Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients.
Samsen A, von der Heyde S, Bokemeyer C, David KA, Flath B, Graap M, Grebenstein B, Heflik L, Hollburg W, Layer P, von Leitner E, Overkamp F, Saeger W, Schneider S, von Seydewitz CU, Stang A, Stein A, Zornig C, Juhl H.
Samsen A, et al. Among authors: juhl h.
Oncotarget. 2018 Oct 5;9(78):34794-34809. doi: 10.18632/oncotarget.26198. eCollection 2018 Oct 5.
Oncotarget. 2018.
PMID: 30410678
Free PMC article.